menu
    • menu

    Company profile for AnaptysBio

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AnaptysBio is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates to patients. We are focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. We develop our product candidates using our proprietary antibody discovery technology platform, which is based upon a breakthrough understanding of the natural process of antibody gen...
    AnaptysBio is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates to patients. We are focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. We develop our product candidates using our proprietary antibody discovery technology platform, which is based upon a breakthrough understanding of the natural process of antibody generation, known as somatic hypermutation, or SHM, and replicates this natural process of antibody generation in vitro. Our strategy is to advance the development of our proprietary product candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AnaptysBioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10421 Pacific Center Court Suite 200 San Diego, CA 92121
    Telephone
    Telephone
    (858) 362-6295
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.anaptysbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anaptys Announces Participation In December Investor Conferences
    Anaptys Announces Participation In December Investor Conferences

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194748/0/en/Anaptys-Announces-Participation-in-December-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    GSK, Anaptysbio sue each other over Jemperli revenue
    GSK, Anaptysbio sue each other over Jemperli revenue

    22 Nov 2025

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/anaptysbio-gsk-tesaro-sue-jemperli-royalty/806168/

    BIOPHARMADIVE
    22 Nov 2025
    Share Share
    Anaptys Announces $100 Million Stock Repurchase Plan
    Anaptys Announces $100 Million Stock Repurchase Plan

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192563/0/en/Anaptys-Announces-100-Million-Stock-Repurchase-Plan.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share
    Anaptysbio Abandons Rosnilimab For UC After Phase 2 Fail
    Anaptysbio Abandons Rosnilimab For UC After Phase 2 Fail

    10 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/anaptysbio-abandons-rosnilimab-ulcerative-colitis-after-phase-2-fail

    FIERCE BIOTECH
    10 Nov 2025
    Share Share
    Anaptys Reveals Q3 2025 Financials & Business Update
    Anaptys Reveals Q3 2025 Financials & Business Update

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180905/0/en/Anaptys-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Anaptys Announces Participation In November Investor Conferences
    Anaptys Announces Participation In November Investor Conferences

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180904/0/en/Anaptys-Announces-Participation-in-November-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search